Benzinga's Top Pre-Market Losers

Progenics Pharmaceuticals PGNX shares fell 47.22% to $5.70 in the pre-market trading. Salix Pharmaceuticals Ltd SLXP and Progenics Pharmaceuticals received a Complete Response Letter from the US Food and Drug Administration (FDA) for a Supplemental New Drug Application (sNDA) for RELISTOR. Salix Pharmaceuticals Ltd SLXP dipped 15.42% to $44.99 in the pre-market session. Analysts at Susquehanna downgraded Salix from “positive” to “neutral.” Green Mountain Coffee Roasters GMCR moved down 1.88% to $17.70 in the pre-market session. Green Mountain Coffee Roasters shares have dropped 82.65% over the past 52 weeks, while the S&P 500 index has gained 7.25% in the same period. Masco MAS dipped 1.58% to $13.09 in the pre-market session. Masco is expected to report its Q2 earnings after the closing bell.